HSCS (HeartSciences) Other Gross PPE : $0.94 Mil (As of Jul. 2024)

View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Other Gross PPE?

HeartSciences's Other Gross PPE for the quarter that ended in Jul. 2024 was $0.94 Mil.

HeartSciences's quarterly Other Gross PPE increased from Jan. 2024 ($0.93 Mil) to Apr. 2024 ($0.96 Mil) but then declined from Apr. 2024 ($0.96 Mil) to Jul. 2024 ($0.94 Mil).

HeartSciences's annual Other Gross PPE increased from Apr. 2022 ($0.50 Mil) to Apr. 2023 ($0.96 Mil) but then declined from Apr. 2023 ($0.96 Mil) to Apr. 2024 ($0.96 Mil).

HeartSciences Other Gross PPE Historical Data

The historical data trend for HeartSciences's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Other Gross PPE Chart

HeartSciences Annual Data

Trend

Apr20

Apr21

Apr22

Apr23

Apr24

Other Gross PPE

0.70

0.61

0.50

0.96

HeartSciences Quarterly Data
	Apr20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Other Gross PPE	Get a 7-Day Free Trial											0.95	0.94	0.93	0.96	0.94

HeartSciences Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

HeartSciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

550 Reserve Street, Suite 360, Southlake, TX, USA, 76092

Website

https://www.heartsciences.com

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Executives

David R. Wells	director	2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent	director	750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz	director, officer: See Remarks	3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson	officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson	director, officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092